Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users
A Focus on Cannabinoid Content and Cannabis for Medical Purposes
Bibliographic Data
| ID | 15525784 |
|---|---|
| Authors | Hollis C Karoly (0000-0002-1232-1202, Colorado State University, corresponding author), Raeghan L Mueller (0000-0001-5249-1532, University of Colorado Boulder), Chrysta C Andrade (University of Colorado Boulder), Kent E Hutchison (0000-0002-4805-9277, University of Colorado Boulder) |
| Year | 2020 |
| Volume | 11 |
| Pages | 613243-613243 |
| Publication date | 2020-12-21 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2020.613243 |
| PMID | 33408657 |
| OpenAlex | W3117031349 |
| Language | EN |
| Citations received | 3 |
| References cited | 9 |
Cannabis is commonly used among people who drink alcohol, but findings are mixed regarding the direction of this relationship. The type of cannabis used [high-cannabidiol (CBD) vs. high-delta-9tetrahydrocannabinol (THC)] and motives for use (i.e., whether cannabis is used to treat a medical condition) may influence the relationship between cannabis and drinking. Specifically, CBD has shown preclinical promise in reducing alcohol consumption, and medical cannabis users report using cannabis to reduce drinking. This study leverages survey data from cannabis users who drink alcohol ( N = 533). Respondents were categorized as using cannabis to treat (CTT) a medical condition or as individuals whose cannabis use is not intended to treat (NCTT) a medical condition and grouped based on the THC/CBD ratio of the flower or edible cannabis they typically use (e.g., "High-THC/CBD," "Medium-THC/CBD" and "Low-THC/CBD"). The CTT group ( n = 412) reported drinking significantly less frequently than the NCTT group ( n = 121). Cannabinoid content of flower cannabis was associated with alcohol consumed on cannabis-use days, such that individuals in the High-THC/CBD group drink more on cannabis-use days compared to the Medium-THC/CBD group. Cannabinoid content of edible cannabis was associated with drinks per drinking occasion, such that the High-THC/CBD group consumed the most drinks and the Low-THC/CBD group consumed the fewest. For both edible and flower groupings, higher-THC/CBD cannabis was associated with more frequent co-use than lower-THC/CBD cannabis. Results suggest that whether someone uses cannabis to treat a medical condition may impact their drinking frequency, and the cannabinoid content in flower and edible cannabis impacts alcohol consumption
Alcohol · Cannabidiol · Cannabinoid · Cannabis · Dronabinol · Psychiatry · Tetrahydrocannabinol · Cannabis and Cannabinoid Research · Chemistry · Medicine · Psychedelics and Drug Studies · Substance Abuse Treatment and Outcomes · Internal Medicine
Analyzing and Interpreting Data From Likert-Type Scales
Simultaneous Versus Concurrent Use of Alcohol and Cannabis in the National Alcohol Survey
Co-use of Alcohol and Cannabis
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption
Likert scales, levels of measurement and the “laws” of statistics
Cannabis as a substitute for alcohol and other drugs
Medical cannabis access, use, and substitution for prescription opioids and other substances
Ordinal Measures in Multiple Indicator Models
| Unique citing works | 3 |
|---|---|
| Citations per year | 1,5 |
| Citation span | 2024 - 2026 (3) |
| Citation velocity | current |
| Highly cited | No |
| Citation types | Neutral: 3 |